Description:
Tenofovir Disoproxil Fumarate and Emtricitabine Tablets is a fixed-dose combination of two antiretroviral agents used primarily for the treatment and prevention of HIV-1 (Human Immunodeficiency Virus) infection. This combination is widely prescribed as part of antiretroviral therapy (ART) in HIV-positive individuals and is also approved for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in high-risk populations.
Composition:
Tenofovir Disoproxil Fumarate (Nucleotide Reverse Transcriptase Inhibitor – NRTI)
Emtricitabine (Nucleoside Reverse Transcriptase Inhibitor – NRTI)
Therapeutic Uses:
Treatment of HIV-1 infection in adults and adolescents, in combination with other antiretroviral agents
Pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 acquisition in at-risk individuals
Mechanism of Action:
Both active ingredients inhibit the HIV reverse transcriptase enzyme, preventing the conversion of viral RNA into DNA, a critical step in the HIV replication cycle. Their combined action reduces viral load and helps prevent the establishment of infection.
Dosage Form:
Tablet
Prescription Status:
Prescription-only medication
Note:
This medication is not a cure for HIV but plays a crucial role in managing the infection and preventing transmission. It must be taken consistently as prescribed and under the supervision of a qualified healthcare provider. Regular monitoring of renal function and HIV status is recommended during treatment or preventive use.
Would you like this formatted for product brochures or digital pharmacy listings?
